DrugPatentWatch Database Preview

Litigation Details for LOUISIANA WHOLESALE DRUG CO., INC. v. SMITHKLINE BEECHAM CORPORATION (D.N.J. 2012)

« Back to Dashboard

LOUISIANA WHOLESALE DRUG CO., INC. v. SMITHKLINE BEECHAM CORPORATION (D.N.J. 2012)

Docket		Date Filed	2012-02-17
Court	District Court, D. New Jersey	Date Terminated	2012-12-06
Cause	15:1 Antitrust Litigation	Assigned To	William H. Walls
Jury Demand	Plaintiff	Referred To	Magistrate Judge Cathy L. Wald
Parties	FEDERAL TRADE COMMISSION; GLAXOSMITHKLINE LLC; KING DRUG COMPANY OF FLORENCE, INC.; LOUISIANA WHOLESALE DRUG CO., INC.; MEIJER DISTRIBUTION, INC.; MEIJER INC.; PHV DEVORA W. ALLON; ROCHESTER DRUG CO-OPERATIVE, INC.; SMITHKLINE BEECHAM CORPORATION; TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS; TEVA PHARMACEUTICALS USA, INC.
Patents	4,602,017; 5,698,226
Attorneys	ALLYN ZISSEL LITE; ELENA K. CHAN; EVAN WAINHOUSE DAVIS; JAMES E. CECCHI; JOSEPH ALDO FISCHETTI; KIMBERLY MARION HENNINGS; LINDSAY DOBRZYNSKI BREEDLOVE; LINDSEY H. TAYLOR; MATTHEW F. GATELY; MELISSA J HATCH; MICHAEL E. PATUNAS; MIGUEL A. POZO; PETER S. PEARLMAN; RYAN JOHN COOPER; TIMOTHY JOHN SLATTERY; TIMOTHY STEPHEN JENKINS
Firms	Federal Trade Commission; Lowenstein Sandler; Pashman Stein
Link to Docket	External link to docket

Details for LOUISIANA WHOLESALE DRUG CO., INC. v. SMITHKLINE BEECHAM CORPORATION (D.N.J. 2012)

Date Filed	Document No.	Description	Snippet	Link To Document
2012-02-17	1		primary exclusivity stemmed from U.S. Patent No. 4,602,017 (“the ‘017 patent”) which GSK listed in the FDA …017 patent, and these cases were subsequently consolidated (the “Patent Litigation”). The Patent Litigation…Lamictal Tablets. The ‘017 patent, along with another patent (U.S. Patent No. 5,698,226), was listed…infringed patent. No relevant regulatory exclusivities extended the life of the ‘017 patent itself per…the ‘017 patent. Thus, even though Teva had already succeeded in invalidating the ‘017 patent’s primary	External link to document
2014-01-24	128		lamotrigine, covered by U.S. Patent No. 4,602,017 (“the ‘017 patent”). Id. ¶ 11. GSK’s patent for lamotrigine…a “quick look”: if a patent holder makes a reverse payment to a generic patent challenger, that payment…validity of the patent; and parties may well find ways to settle patent disputes without…compensates the patent challenger for “other services . . . such as distributing the patented item or helping…skeptically at patent settlements than did courts applying the “scope of the patent” test and there	External link to document
2016-09-26	188	Exhibit A	241” OR “20-764”) “4,602,017” OR “017 patent” OR “5,698,226” OR “226 patent” “2:02-cv-03779” OR…SmithKline*) AND Teva AND (settl* OR licens* OR patent* OR infring* OR agree* OR (hatch w/2 waxman)…SmithKline*) AND Teva AND (settl* OR licens* OR patent* OR infring* OR agree* OR (hatch w/2 waxman)	External link to document
2017-10-18	285		: # 1 Joint Stipulation Regarding U.S. Patent Number 5,698,226)(PEARLMAN, PETER) (Entered: 10/18/2017)	External link to document
2017-10-19	289		JOINT STIPULATION AND ORDER REGARDINGU.S. PATENT NO. 5,698,226. Signed by Magistrate Judge Cathy L. Waldor	External link to document